The case study describes a once successful 30-year old pharmaceutical company that has recently begun struggling under the leadership of the founder's two sons. In a board meeting, it was decided that the company would not be shut down, the sons would be removed, and a new CEO appointed with equal power to the chairman to report directly to him.